In the UC cohort, pathways related to IBD, asthma, and the intestinal immune network for IgA production were activated, whereas those related to the metabolism of xenobiotics by cytochrome P450 and metabolism of drugs by cytochrome P450 were inhibited (Fig. 5F,I). The gene discussed is CD79A; the disease is inflammatory bowel disease.